Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Baldness score can't be used to predict prostate size.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Male pattern baldness does not cause an increased risk of prostate cancer.

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

PSA can help diagnose high androgen levels in women.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Some common medications can lower PSA levels in 45-year-old German men.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Male pattern baldness may predict prostate cancer risk.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Men with pattern baldness may have a higher risk of prostate issues.

The document suggests more research is needed to understand the link between baldness and prostate cancer.